Photo: ca.finance.yahoo.com
Trump Secures Affordable Fertility Drug Deal for IVF Patients
President Donald Trump announced a deal with EMD Serono to reduce costs for a common fertility medication, enhancing access for patients undergoing in vitro fertilisation in the United States.
- The deal between EMD Serono and the Trump administration aims to make a common fertility medication more affordable for patients seeking in vitro fertilisation.
- New federal guidance allows employers to offer fertility benefits independently from major medical insurance plans, similar to existing dental and vision plans.
- This initiative by Donald Trump is part of a broader effort to improve fertility coverage and support for patients in the United States.
Why It Matters
This development is significant as it addresses the financial barriers many face in accessing fertility treatments, potentially increasing the number of individuals undergoing in vitro fertilisation and improving reproductive health outcomes.